RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 86 filers reported holding RAPT THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,392,861 | -28.4% | 805,828 | -19.4% | 1.54% | -12.7% |
| Q2 2023 | $18,700,000 | +16.3% | 1,000,000 | +14.2% | 1.77% | -41.5% |
| Q1 2023 | $16,074,306 | -7.7% | 875,984 | -0.5% | 3.02% | -12.9% |
| Q4 2022 | $17,424,000 | +7.2% | 880,000 | +30.3% | 3.47% | +66.9% |
| Q3 2022 | $16,255,000 | -13.0% | 675,617 | -34.0% | 2.08% | -34.4% |
| Q2 2022 | $18,676,000 | -22.0% | 1,023,321 | -6.0% | 3.17% | +27.0% |
| Q1 2022 | $23,932,000 | -47.8% | 1,088,321 | -12.8% | 2.49% | -52.7% |
| Q4 2021 | $45,851,000 | +28.6% | 1,248,321 | +8.7% | 5.27% | +21.5% |
| Q3 2021 | $35,655,000 | +15.5% | 1,148,321 | +18.3% | 4.34% | +21.3% |
| Q2 2021 | $30,862,000 | +271.7% | 970,821 | +159.6% | 3.58% | +321.7% |
| Q1 2021 | $8,303,000 | +65.8% | 374,021 | +47.5% | 0.85% | +56.5% |
| Q4 2020 | $5,009,000 | – | 253,608 | – | 0.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Column Group LLC | 2,680,621 | $49,189,395 | 17.79% |
| Euclidean Capital LLC | 432,900 | $7,943,715 | 6.97% |
| GREAT POINT PARTNERS LLC | 1,355,151 | $24,867,021 | 4.88% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 875,984 | $16,074,306 | 3.02% |
| Trustees of Columbia University in the City of New York | 80,580 | $1,478,643 | 2.64% |
| Perceptive Advisors | 2,291,608 | $42,051,007 | 1.24% |
| Cormorant Asset Management, LP | 650,000 | $11,928 | 0.79% |
| Alphabet Inc. | 540,270 | $9,913,955 | 0.55% |
| Redmile Group, LLC | 688,132 | $12,627,222 | 0.55% |
| Orbimed Advisors | 1,251,070 | $22,957,135 | 0.45% |